ACADIA PHARMACEUTICALS INC Insider Trading for April 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACADIA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACADIA PHARMACEUTICALS INC for April 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 07 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Option Exercise | M | 1.36 | 10,000 | 13,600 | 0 | ||
| Apr 07 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Option Exercise | M | 1.36 | 55,147 | 75,000 | 0 | ||
| Apr 07 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Option Exercise | M | 1.30 | 57,692 | 75,000 | 0 | ||
| Apr 07 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Option Exercise | M | 1.30 | 10,000 | 13,000 | 0 | ||
| Apr 07 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Buy | M | 1.36 | 10,000 | 13,600 | 132,839 | 122.8 K to 132.8 K (+8.14 %) | |
| Apr 07 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Buy | M | 1.36 | 55,147 | 75,000 | 122,839 | 67.7 K to 122.8 K (+81.47 %) | |
| Apr 07 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Buy | M | 1.30 | 57,692 | 75,000 | 67,692 | 10 K to 67.7 K (+576.92 %) | |
| Apr 07 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Buy | M | 1.30 | 10,000 | 13,000 | 10,000 | 0 to 10 K | |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 28.55 | 262,253 | 7,486,904 | 21,167,398 | 20.9 M to 21.2 M (+1.25 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 28.55 | 28,647 | 817,826 | 2,896,800 | 2.9 M to 2.9 M (+1.00 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 27.82 | 10,818 | 300,959 | 20,905,145 | 20.9 M to 20.9 M (+0.05 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 27.82 | 1,182 | 32,883 | 2,868,153 | 2.9 M to 2.9 M (+0.04 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 27.72 | 318,969 | 8,840,959 | 20,894,327 | 20.6 M to 20.9 M (+1.55 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 27.72 | 34,844 | 965,782 | 2,866,971 | 2.8 M to 2.9 M (+1.23 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 27.56 | 60,587 | 1,669,705 | 20,575,358 | 20.5 M to 20.6 M (+0.30 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 27.56 | 6,618 | 182,384 | 2,832,127 | 2.8 M to 2.8 M (+0.23 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 26.55 | 28,433 | 755,024 | 20,514,771 | 20.5 M to 20.5 M (+0.14 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 26.55 | 3,106 | 82,478 | 2,825,509 | 2.8 M to 2.8 M (+0.11 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 26.49 | 180,122 | 4,772,224 | 20,486,338 | 20.3 M to 20.5 M (+0.89 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 26.49 | 19,676 | 521,304 | 2,822,403 | 2.8 M to 2.8 M (+0.70 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 26.29 | 13,433 | 353,086 | 20,306,216 | 20.3 M to 20.3 M (+0.07 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 26.29 | 1,467 | 38,560 | 2,802,727 | 2.8 M to 2.8 M (+0.05 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 25.61 | 14,775 | 378,343 | 20,292,783 | 20.3 M to 20.3 M (+0.07 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 25.61 | 1,614 | 41,330 | 2,801,260 | 2.8 M to 2.8 M (+0.06 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 26.35 | 16,057 | 423,057 | 2,799,646 | 2.8 M to 2.8 M (+0.58 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 25.98 | 37,882 | 983,985 | 2,783,589 | 2.7 M to 2.8 M (+1.38 %) |
| Apr 01 2016 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 25.92 | 408,607 | 10,593,014 | 2,745,707 | 2.3 M to 2.7 M (+17.48 %) |
| Apr 20 2016 | ACAD | ACADIA PHARMACEUTI ... | Iversen Leslie L | Option Exercise | M | 1.75 | 33,697 | 58,970 | 0 | ||
| Apr 20 2016 | ACAD | ACADIA PHARMACEUTI ... | Iversen Leslie L | Sell | S | 33.53 | 33,697 | 1,129,999 | 36,127 | 69.8 K to 36.1 K (-48.26 %) | |
| Apr 20 2016 | ACAD | ACADIA PHARMACEUTI ... | Iversen Leslie L | Buy | M | 1.75 | 33,697 | 58,970 | 69,824 | 36.1 K to 69.8 K (+93.27 %) |